SBS
I was not surprised that the genetically modified safflower product was approved by FDA. But, somewhat like the issue with GTCB prior to approval of ATRYN there was lingering worry that a bioengineered product might meet an uncertain fate when reviewed by FDA.
Sorry, I don't know much about the other partners mentionned, except that I think Arcadia is involved with nutraceuticals and is subsidized by Canadian fed or provincial government. It was a partner in the SBS-Botaneco spinoff .
urche
Market Data 
Markets 
AI
